Kevin C. Gorman

2017

In 2017, Kevin C. Gorman earned a total compensation of $7.6M as Chief Executive Officer at Neurocrine Biosciences, a 43% increase compared to previous year.

Compensation breakdown

Bonus$515,200
Option Awards$4,929,898
Salary$640,000
Stock Awards$1,426,920
Other$44,356
Total$7,556,374

Gorman received $4.9M in option awards, accounting for 65% of the total pay in 2017.

Gorman also received $515.2K in bonus, $640K in salary, $1.4M in stock awards and $44.4K in other compensation.

Rankings

In 2017, Kevin C. Gorman's compensation ranked 1,038th out of 14,666 executives tracked by ExecPay. In other words, Gorman earned more than 92.9% of executives.

ClassificationRankingPercentile
All
1,038
out of 14,666
93rd
Division
Manufacturing
352
out of 5,772
94th
Major group
Chemicals And Allied Products
93
out of 2,075
96th
Industry group
Drugs
62
out of 1,731
96th
Industry
Biological Products, Except Diagnostic Substances
10
out of 313
97th
Source: SEC filing on April 17, 2019.

Gorman's colleagues

We found four more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2017.

2017

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

2017

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2017

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

2017

Kyle Gano

Neurocrine Biosciences

Chief Business Development Officer

News

In-depth

You may also like